Stitching together three key factors enables understanding of the 2024 vote: tyranny, the need to manufacture a distinction ...

The End-of-Phase 2 meeting resulted in alignment with the FDA on the proposed Phase 3 study design, including the inclusion/exclusion criteria, primary and secondary efficacy objectives, definition of ...